Incyte Corp.

NASDAQ:INCY   3:59:44 PM EDT
90.34
+0.65 (+0.72%)
Products

Eli Lilly Says Continuing Conversations With U.S. FDA Around Potential For EUA Of Baricitinib

Published: 10/08/2020 17:35 GMT
Incyte Corp (INCY) - Baricitinib Has Significant Effect on Recovery Time, Most Impactful in Covid-19 Patients Requiring Oxygen.
Eli Lilly and Co - Continuing Conversations With U.S. FDA Around Potential for Eua of Baricitinib to Treat Hospitalized Patients With Covid-19.